Home Technology Novo Owner Backs Italy Fund to Spur Drug Startups Beyond Denmark
Technology

Novo Owner Backs Italy Fund to Spur Drug Startups Beyond Denmark

Novo Owner Backs Italy Fund to Spur Drug Startups Beyond Denmark
Key Points

Novo Owner Backs Italy Fund to Spur Drug Startups Beyond Denmark Novo Nordisk A/S’s biggest shareholder is investing in a new Italian startup accelerator, part of an effort to foster early stage life science companies across Europe. Novo Holdings is contributing €5 million ($5.7 million) of an initial €25 million in funding, with the rest coming from regional development agency Lazio Innova, according to a statement. The Rome-based accelerator will be run by Copenhagen-based BioInnovation...

Novo Owner Backs Italy Fund to Spur Drug Startups Beyond Denmark Novo Nordisk A/S’s biggest shareholder is investing in a new Italian startup accelerator, part of an effort to foster early stage life science companies across Europe. Novo Holdings is contributing €5 million ($5.7 million) of an initial €25 million in funding, with the rest coming from regional development agency Lazio Innova, according to a statement. The Rome-based accelerator will be run by Copenhagen-based BioInnovation Institute, which has backed more than a hundred startups, including Embark Biotech, a company later purchased by the Danish maker of Ozempic.
Novo Owner Backs Italy Fund to (ORG) Spur Drug Startups Beyond (ORG) Denmark (LOCATION) Denmark Novo Nordisk A/S’s (ORG) Italian (ORG) Europe (LOCATION) Novo Holdings (ORG) Lazio Innova (PERSON) Rome (LOCATION) Copenhagen (LOCATION) BioInnovation Institute (ORG) Embark Biotech (ORG) Danish (ORG) Ozempic (ORG)
Originally published by Bloomberg Technology Read original →